Retraction
Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy
Paper Information
Record ID:
59907
Author(s):
Publication Date:
August 10, 2022
Retraction Date:
December 06, 2023
(2.0 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (5)
5
Total Citations1
Post-Retraction(20.0%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
423
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity
Ziyu Guo, Yihuang Liu, Danyao Chen et al. (10 authors)
Journal of Translational Internal Medicine
Published: Feb 2025
7 citations
7 citations
423 days after retraction
Tumor Targeting with Apatinib-loaded Nanoparticles and Sonodynamic Combined Therapy
Xiao Han, Caifu Zhou, Xiaoling Luo et al. (9 authors)
Current Molecular Medicine
Published: Jun 2023
6 citations
6 citations
175 days before retraction
Evaluation of Serum Fructosamine as Diagnostic Marker of Postoperative Recurrence in the Patients with Breast Cancer
Yuanqing Zhao, Xuelong Xie, Jingling Xie et al. (7 authors)
BioMed Research International
Open Access
Published: Jan 2023
1 citation
1 citation
339 days before retraction
Retracted: Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy
Evidence-Based Complementary and Alternative Medicine
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2023
339 days before retraction
Quick Stats
Total Citations:
7
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025